These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18374513)

  • 1. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
    Videtic GM; Rice TW; Murthy S; Suh JH; Saxton JP; Adelstein DJ; Mekhail TM
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):702-6. PubMed ID: 18374513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
    Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].
    Melek H; Günlüoğlu MZ; Demir A; Akin H; Medetoğlu B; Kara HV; Olçmen A; Dinçer SI
    Tuberk Toraks; 2008; 56(1):56-63. PubMed ID: 18330756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
    Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer.
    Melek H; Gunluoglu MZ; Demir A; Akin H; Olcmen A; Dincer SI
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):294-9. PubMed ID: 18096398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology of non-small cell lung cancer.
    Smith DE; Fernandez Aramburu J; Da Lozzo A; Montagne JA; Beveraggi E; Dietrich A
    Updates Surg; 2019 Dec; 71(4):741-746. PubMed ID: 31552569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
    Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
    Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients.
    Carnochan FM; Walker WS
    Eur J Cardiothorac Surg; 2009 May; 35(5):781-4; discussion 784-5. PubMed ID: 19272791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer.
    Kunst PW; Lee P; Paul MA; Senan S; Smit EF
    J Thorac Oncol; 2007 Oct; 2(10):912-5. PubMed ID: 17909353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.
    Sanli M; Isik AF; Zincirkeser S; Elbek O; Mete A; Tuncozgur B; Elbeyli L
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1200-5. PubMed ID: 19660381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of mediastinoscopy and surgery with or without neoadjuvant therapy in patients with non-small cell lung cancer who are N2 negative on positron emission tomography and computed tomography.
    Kim HK; Choi YS; Kim K; Shim YM; Park K; Ahn YC; Lee KS; Choi JY; Kim J
    J Thorac Oncol; 2011 Feb; 6(2):336-42. PubMed ID: 21164366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer.
    Carrillo SA; Daniel VC; Hall N; Hitchcock CL; Ross P; Kassis ES
    Ann Thorac Surg; 2012 May; 93(5):1621-4. PubMed ID: 22429676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocol.
    Hehr T; Friedel G; Steger V; Spengler W; Eschmann SM; Bamberg M; Budach W
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1376-81. PubMed ID: 19864078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK; Lee KS; Kim BT; Choi JY; Kim H; Kwon OJ; Shim YM; Yi CA; Kim HY; Chung MJ
    Cancer; 2007 Mar; 109(6):1068-77. PubMed ID: 17311309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy.
    Eloubeidi MA; Tamhane A; Chen VK; Cerfolio RJ
    Ann Thorac Surg; 2005 Oct; 80(4):1231-9. PubMed ID: 16181845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.